Cellbxhealth PLC
ANPCF • Medical - Diagnostics & Research
$0.02
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$6.42M
Growth
-9.8%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 22.7%Manageable debt level · 0.23Healthy liquidity · 5.04Weak profitability
Financial data as of: Jun 30, 2025, 12:00 AM UTCLast earnings update: Sep 9, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.02
Change0.00%
Shares Out322.53M
Market Cap$6.42M
52W Range0.01 - 0.16
Beta0.41
P/E-1.34
P/S62.60
P/B2.13
P/FCF-10.64
EV/Sales58.57
EV/EBITDA-5.05
Price$0.02
Change0.00%
Shares Out322.53M
Market Cap$6.42M
52W Range0.01 - 0.16
Beta0.41
P/E-1.34
P/S62.60
P/B2.13
P/FCF-10.64
EV/Sales58.57
EV/EBITDA-5.05
EV/FCF-9.95
Earnings Yield-18.60%
FCF Yield-9.40%
Dividend Yield0.00%
Gross Margin62.16%
Oper. Margin-5.27%
Profit Margin-4.97%
Debt/Eq0.23
Current Ratio5.04
Quick Ratio4.55
Revenue 5Y-9.84%
Volume20.00K
Avg Volume797.00
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
53/100
Why this score▼
Positive revenue growth · 22.7%Manageable debt level · 0.23Healthy liquidity · 5.04Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.